Dr. Marc Matrana of the Ochsner Medical Center Hematology and Oncology Department has been named one of the leading faculty members for an annual worldwide meeting of renal cell carcinoma experts in Paris in November. The symposium brings together the world’s most respected researchers and clinicians in the field.
Dr. Matrana will deliver the meeting’s plenary address on real-world experiences using targeted therapies—so called “smart bombs”—to treat inoperable metastatic kidney cancer. He will also moderate a workshop addressing key considerations in selecting appropriate treatments for individual patients and will participate in several panels discussing the optimization of personalized cancer therapies for kidney cancer.
Dr. Matrana completed his internal medicine residency at Ochsner and served as Chief Medical Resident before joining MD Anderson Cancer Center in Houston in 2010 where he served as the Chief of the Hematology and Medical Oncology Program. He was recruited back to Ochsner and rejoined the staff in September 2013. Dr. Matrana presented his research findings from a large retrospective kidney cancer study at the European Cancer Congress in Amsterdam in September and published the results of another celebrated study in the European Journal of Cancer earlier this year. This work and other related studies resulted in Dr. Matrana’s invitation to lead the worldwide gathering of cancer experts.
Dr. Matrana is an active researcher in the Ochsner Cancer Institute and is the Assistant Program Director of the Medical Oncology Fellowship. He also holds faculty positions with the Ochsner Internal Medicine Residency Program and with The University of Queensland School of Medicine, Ochsner Clinical School.